A single centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intramuscular single-visit dosing regimen of purified chick-embryo cell-culture rabies vaccine in adults.

  • Soentjens, Patrick (Promotor)
  • Everaert, Maude (Researcher)
  • Vanden Berghe, Emily (Researcher)

    Project: Research

    Project Details

    Funding acknowledgement

    The project SINGLE-R - HFM/21-13 is financed under the DFR call.
    AcronymSINGLE-R
    StatusActive
    Effective start/end date1/01/21 → 30/06/26

    Collaborative partners

    RHID domain

    • Human factors and medecine

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
    View full fingerprint